Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px
All >

News > Austria

Total search results: 127 | Ordered by Date (descending)
1 2  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Graph Therapeutics FlexCo. (1/9/25). "Press Release: Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases". Vienna. 2025-01-09
Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein. 2024-12-16
Infrareal Holding GmbH & Co. KG. (11/20/24). "Press Release: Infrareal Takes Over Pharmaceutical and Biotech Site in Orth, Lower Austria". Gütersloh. 2024-11-20
Valanx Biotech GmbH. (10/29/24). "Press Release: Valanx Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development". Klosterneuburg & Rockville, MD. 2024-10-29
UpNano GmbH. (10/17/24). "Press Release: Industry Groups Invest in High Performance 2PP 3D Print Technology". Vienna. 2024-10-17
Invios GmbH. (10/15/24). "Press Release: Invios Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-oncology". Vienna. 2024-10-15
a:head bio AG. (10/9/24). "Press Release: a:head Secures Pre-Series A Funding and Appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board". Vienna. 2024-10-09
Aitiologic GmbH. (10/1/24). "Press Release: Aitiologic Emerges from Stealth Mode with over €2.5M in Funding to Advance AI-powered Liquid Biopsy Platform for Early Disease Detection". Vienna. 2024-10-01
1BillionLives GmbH (d/b/a Flinn). (9/30/24). "Press Release: Flinn.ai Secures 10 Million Euros in Less than 18 Months". 2024-09-30
Boehringer Ingelheim Stiftung / ÖAW. (9/18/24). "Press Release: OeAW and Boehringer Ingelheim Foundation Establish New Institute for Biomedical Artificial Intelligence in Vienna". Mainz. 2024-09-18
Apeiron Biologics AG. (7/8/24). "Press Release: Apeiron Biologics to Be Acquired by Ligand Pharmaceuticals for USD 100 Million". Vienna. 2024-07-08
SciRhom GmbH. (6/12/24). "Press Release: SciRhom Announces Approval of First Clinical Trial Application for a Novel iRhom2-targeting Antibody Against Autoimmune Diseases". Munich. 2024-06-12
Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna. 2024-06-04
Ygion Biomedical GmbH. (5/21/24). "Press Release: Ygion Biomedical Announces €15 Million Series A Financing to Develop Individualized Cancer Immunotherapies". 2024-05-21
Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. 2024-05-15
Neurolentech GmbH. (4/22/24). "Press Release: Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research". Klosterneuburg. 2024-04-22
IMBA – Institute of Molecular Biotechnology GmbH. (3/14/24). "Press Release: Elly Tanaka – IMBA’s New Scientific Director". 2024-03-14
Boehringer Ingelheim. (2/8/24). "Press Release: Boehringer Ingelheim and CBmed Join Forces to Translate Novel Cancer Therapy Approaches Faster into New Medicines for Patients". Ingelheim & Graz. 2024-02-08
Hephaistos-Pharma SAS. (1/23/24). "Press Release: Hephaistos-Pharma Secures a €2 Million Seed Round with Xista Science Ventures, Foundation Fournier-Majoie and Noshaq". Orsay. 2024-01-23
Evomedis GmbH. (11/23/23). "Press Release: Evomedis Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation". Graz. 2023-11-23
OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection". 2023-11-07
Valanx Biotech GmbH. (11/7/23). "Press Release: Valanx Biotech Announces Successful Fundraise of 2.3 M EUR". Klosterneuburg. 2023-11-07
HeartBeat.bio AG. (11/02/23). "Press Release: HeartBeat.bio Raises € 4.5 Million in Pre-Series A Financing to Drive Development of Organoid Screening Platform for Cardiac Drug Discovery". Vienna. 2023-11-02
CMBlu Energy AG. (10/23/23). "Press Release: Technology Group STRABAG Invests 100 Million Euros into Battery and Energy Storage Company CMBlu Energy". Alzenau. 2023-10-23
Biotech Austria. (10/17/23). "Press Release: Inaugural Biotech Summit Austria Sets the Agenda for Emerging Biotech Innovation". Graz. 2023-10-17
Orakl Oncology SAS. (10/4/23). "Press Release: Orakl Oncology Raises €3 Million to Develop Its Techbio Platform for Precision Oncology". Paris. 2023-10-04
Kern Tec. (9/27/23). "Press Release: Kern Tec Raises €12 Million in Series A Funding to Scale Technology that Turns Food Waste into Food Ingredients". Vienna. 2023-09-27
Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna. 2023-09-05
Nyra Health GmbH. (6/22/23). "Press Release: Nyra Health Raises €4.5m Seed Round to Advance Its Digital Neuro-therapy". Vienna, Munich & Singapore. 2023-06-22
QbD Group. (5/25/23). "Press Release: The QbD Group Acquires Michor Consulting to Enhance Its Regulatory Affairs Services across Europe". 2023-05-25
aws Gründerfonds. (5/24/23). "Pressemitteilung: aws Gründungsfonds II. Neuer Venture Capital Fonds für innovative Technologien sucht die besten Start-ups". 2023-05-24
Evomedis GmbH. (5/12/23). "Press Release: European Commission Grants Orphan Drug Designation for EVOCellic". 2023-05-12
LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer". 2023-05-02
Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna. 2023-04-05
Quantro Therapeutics GmbH. (4/4/23). "Press Release: Quantro Therapeutics Appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer". Vienna. 2023-04-04
Proxygen GmbH. (3/15/23). "Press Release: Proxygen Announces Formation of Board of Directors". Vienna. 2023-03-15
aws Gründerfonds. (12/23/22). "Pressemitteilung: aws Gründerfonds investiert in nachhaltiges Lebensmittel-Startup Arkeon". Tulln & Wien. 2022-12-23
Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. 2022-11-17
Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. 2022-10-19
HeartBeat.bio AG. (10/5/22). "Press Release: HeartBeat.bio Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna. 2022-10-05
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". 2022-09-27
HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA. 2022-09-12
Quantro Therapeutics GmbH. (8/3/22). "Press Release: Quantro Therapeutics Collaborates with Boehringer Ingelheim to Develop Drug Candidates Interfering with Transcriptional Regulators". Vienna. 2022-08-03
Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad. 2022-08-02
UpNano GmbH. (7/5/22). "Press Release: Fresh Capital Boosts Innovation and Use in Serial Production. UpNano Further Strengthens R&D and US Expansion with Capital Increase". Vienna. 2022-07-05
Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. 2022-06-02
Apeiron Biologics AG. (4/26/22). "Press Release: Apeiron Shareholders Approve New Group Structure Geared towards Enabling Innovation and Growth". Vienna. 2022-04-26
Celeris Therapeutics GmbH. (4/4/22). "Press Release: Celeris Therapeutics and Boehringer Ingelheim Enter Collaboration to Develop Next-generation Targeted Protein Degraders". Menlo Park, CA. 2022-04-04
European Invesmtent Bank (EIB). (3/24/22). "Press Release: Austria – EIB Supports Innovacell’s Innovative Cell Therapy for Treating Incontinence". 2022-03-24
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. 2022-02-15
Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. 2022-02-10
Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. 2022-02-09
Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". 2022-02-02
Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. 2022-01-31
Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck. 2022-01-24
Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg. 2022-01-21
Sanofi S.A.. (12/1/21). "Press Release: Sanofi to Acquire Origimm Biotechnology in First Move to Treat Acne with Vaccine-based Immunotherapy". Paris & Vienna. 2021-12-01
aws Gründerfonds. (11/23/21). "Press Release: Innerspace Receives Seven-figure Investment". Vienna. 2021-11-23
EIT Health e.V.. (11/9/21). "Press Release: EIT Health-supported PhagoMed Acquired by BioNTech". 2021-11-09
Celeris Therapeutics GmbH. (11/1/21). "Press Release: Celeris Therapeutics, the Pioneer in AI-driven Degrader Design, Builds Laboratories in Austria". Graz. 2021-11-01
Boehringer Ingelheim. (10/6/21). "Press Release: Boehringer Ingelheim Inaugurates Biopharmaceutical Production Facility in Vienna, Austria". Ingelheim. 2021-10-06
Hookipa Pharma Inc.. (10/6/21). "Press Release: Groundbreaking Ceremony for Hookpia’s New Production Site". Vienna. 2021-10-06
Delta 4 GmbH. (9/27/21). "Press Release: Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board". Vienna. 2021-09-27
Celeris Therapeutics GmbH. (8/27/21). "Press Release: Celeris Therapeutics Welcomes Life Sciences and Technology Thought Leader Ian Marks as a Non-Executive Director". Menlo Park, CA. 2021-08-27
AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne. 2021-07-27
High-Tech Gründerfonds Management GmbH. (7/5/21). "Press Release: Cutanos Closes First Financing Round with Investor Consortium from Austria and Germany". Vienna. 2021-07-05
Max Planck Innovation GmbH. (7/5/21). "Press Release: Targeted Immune Stimulation for more Effective Vaccines. Cutanos, a Spin-off from the Max Planck Society, Is Developing Novel Vaccines and Immunotherapies". 2021-07-05
Delta 4 GmbH. (6/25/21). "Press Release: Alfred Steininger to Join Delta4 as CFO". 2021-06-25
Exscientia Ltd.. (6/15/21). "Press Release: Exscientia Acquires Personalised Medicine AI Pioneer Allcyte". 2021-06-15
BASF SE. (5/3/21). "Press Release: BASF Strengthens Its Global Production Footprint for Enzymes. BASF Will Invest at Novartis’ Kundl/Schaftenau Campus, in Austria". 2021-05-03
Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. 2021-04-07
Allcyte GmbH. (3/25/21). "Press Release: Austrian Biotech Allcyte Raises $6m Seed Round Following Breakthrough Cancer Clinical Trial". 2021-03-25
Chemieanlagenbau Chemnitz GmbH. (3/1/21). "Press Release: CAC Builds Biofuel Plant for OMV in Schwechat (A)". Chemnitz. 2021-03-01
Sarcura GmbH. (3/21). "Press Release: Sarcura Received a 1.5 m € Research Grant from FFG". 2021-03-01
Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. 2021-02-22
Novartis AG. (2/11/21). "Press Release: Sandoz Announces Agreement to Acquire GSK’s Cephalosporin Antibiotics Business, Reinforcing Its Leading Global Position in Antibiotics". Basel. 2021-02-11
Sarcura GmbH. (1/31/21). "Press Release: Sarcura and imec to Collaborate on High Throughput Cytometry Solution for Automated (T-)Cell Separation, Tackling Manufacturing Challenges of CGT". Klosterneuburg & Leuven. 2021-01-31
Biotech Austria. (12/10/20). "Press Release: Austria’s Biotechnology Companies Establish Biotech Austria – Biotech Industry Association". Vienna. 2020-12-10
OpGen, Inc.. (12/9/20). "Press Release: OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics". Gaithersburg, MD & Vienna. 2020-12-09
Boehringer Ingelheim. (12/7/20). "Press Release: Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders – a Novel Approach to Fight Cancer". Ingelheim & Vienna. 2020-12-07
Sarcura GmbH. (11/19/20). "Press Release: Sarcura Raises a 2.5 M€ Seed Round. Start-up Advances Their Transformative Manufacturing Platform for Autologous Cell Therapies". Klosterneuburg. 2020-11-19
Apeiron Biologics AG. (11/9/20). "Press Release: Apeiron Biologics AG and Domainex Ltd Announce the Expansion of Their Partnership to Progress Targeted Cancer Immune Therapy Drug Discovery". Vienna & Saffron Waldon. 2020-11-09
Biosynth Carbosynth. (11/3/20). "Press Release: Biosynth Carbosynth Expands Its Enzyme Offerings with Products for Industrial Applications". 2020-11-03
Proxygen GmbH. (7/31/20). "Press Release: Boehringer Ingelheim Awards Proxygen with BI Innovation Prize". Vienna. 2020-07-31
Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. 2020-07-21
DeepSpin GmbH. (6/30/20). "Press Release: Berlin-based DeepSpin Raises Seed Round to Revolutionize Medical Imaging". Berlin. 2020-06-30
Apeiron Biologics AG. (6/3/20). "Press Release: Apeiron Biologics Closes Oversubscribed Financing Round of EUR 17.5 Million for the Development of APN01 against COVID-19". Vienna. 2020-06-03
Delta 4 GmbH. (6/2/20). "Press Release: Delta 4 Announces Results Achieved with Drug Discovery Platform". Vienna. 2020-06-02
Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ. 2020-05-26
Apeiron Biologics AG. (5/18/20). "Press Release: Apeiron Biologics Announces Financing Round for the Further Development of the COVID-19 Drug APN01". Vienna. 2020-05-18
Apeptico Forschung und Entwicklung GmbH. (4/7/20). "Press Release: Solatide Has Been Approved by the Austrian Federal Office for Safety in Health Care for the Treatment of COVID-19 Patients with Severe Pulmonary Dysfunction". Vienna. 2020-04-07
Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. 2020-04-06
Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. 2020-04-06
Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. 2020-04-02
OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. 2020-03-18
Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. 2020-03-04
ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. 2020-02-11
CellTool GmbH. (1/20/20). "Press Release: CellTool Appoints Wulf Fischer-Knuppertz as CEO". Tutzing. 2020-01-20
1 2  next pagenext page



Advertisement

Picture Berlin Partner Life Sciences Report 2024-2025 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Swiss Biotech Association LSG Global Village 2025 Basel 650x300px

» top